scholarly article | Q13442814 |
P50 | author | Ji Sung Yoon | Q81337201 |
P2093 | author name string | Hyoung Woo Lee | |
P2860 | cites work | Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial | Q44599698 |
Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome | Q45180875 | ||
Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients | Q46533533 | ||
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis | Q46810855 | ||
Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA) | Q57281927 | ||
Statins and new-onset diabetes—the important questions | Q57606219 | ||
Direct Effect of Cholesterol on Insulin Secretion: A Novel Mechanism for Pancreatic -Cell Dysfunction | Q60642303 | ||
A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia | Q72577492 | ||
Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease | Q79368237 | ||
Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia | Q79788074 | ||
Are statins diabetogenic? | Q24630205 | ||
Nitric oxide induces apoptosis via Ca2+-dependent processes in the pancreatic beta-cell line MIN6 | Q28372031 | ||
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials | Q29622947 | ||
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study | Q31829404 | ||
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial | Q33966645 | ||
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis | Q34027392 | ||
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials | Q34142678 | ||
Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. | Q34245974 | ||
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial | Q34293369 | ||
Standards of medical care in diabetes--2011. | Q34425055 | ||
Safety and efficacy of statins in Asians | Q34574500 | ||
Rosuvastatin in older patients with systolic heart failure | Q34710349 | ||
Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells | Q35028546 | ||
Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes | Q36294928 | ||
Risk of incident diabetes among patients treated with statins: population based study. | Q36871618 | ||
Statin therapy and risk of developing type 2 diabetes: a meta-analysis | Q37364976 | ||
Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis | Q37632786 | ||
Differential metabolic effects of distinct statins. | Q37815804 | ||
Coenzyme q10 and statin-induced mitochondrial dysfunction. | Q37878308 | ||
Management of cardiovascular risk: the importance of meeting lipid targets | Q38018650 | ||
Statins are diabetogenic--myth or reality? | Q38028072 | ||
Do statins cause diabetes? | Q38086101 | ||
Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks | Q38127588 | ||
Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials | Q39765409 | ||
Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells | Q39965445 | ||
Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control | Q42802278 | ||
Modulation of insulin secretion from normal rat islets by inhibitors of the post-translational modifications of GTP-binding proteins | Q42814670 | ||
Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes | Q42823990 | ||
Effect of pravastatin on the development of diabetes and adiponectin production | Q42829765 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P304 | page(s) | 415-422 | |
P577 | publication date | 2013-12-01 | |
P1433 | published in | Diabetes & metabolism journal | Q26842420 |
P1476 | title | Diabetogenic effect of statins: a double-edged sword? | |
P478 | volume | 37 |
Q36835349 | Association of statin use and stress-induced hyperglycemia in patients with acute ST-elevation myocardial infarction |
Q26783435 | Effects of Vaccinium Berries on Serum Lipids: A Meta-Analysis of Randomized Controlled Trials |
Q55313005 | Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization. |
Q38890066 | Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea |
Q38599323 | Statins and their increased risk of inducing diabetes |
Q38976878 | Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans |
Search more.